Artificial intelligence (AI) agents are emerging as transformative tools in drug discovery, with the ability to autonomously reason, act, and learn through complicated research workflows. Building on large language models (LLMs) coupled with perception, computation, action, and memory tools, these agentic AI systems could integrate diverse biomedical data, execute tasks, carry out experiments via robotic platforms, and iteratively refine hypotheses in closed loops. We provide a conceptual and technical overview of agentic AI architectures, ranging from ReAct and Reflection to Supervisor and Swarm systems, and illustrate their applications across key stages of drug discovery, including literature synthesis, toxicity prediction, automated protocol generation, small-molecule synthesis, drug repurposing, and end-to-end decision-making. To our knowledge, this represents the first comprehensive work to present real-world implementations and quantifiable impacts of agentic AI systems deployed in operational drug discovery settings. Early implementations demonstrate substantial gains in speed, reproducibility, and scalability, compressing workflows that once took months into hours while maintaining scientific traceability. We discuss the current challenges related to data heterogeneity, system reliability, privacy, and benchmarking, and outline future directions towards technology in support of science and translation.

Large language models often mishandle psychiatric emergencies, offering harmful or inappropriate advice and enabling destructive behaviors. This study evaluated the Verily behavioral health safety filter (VBHSF) on two datasets: the Verily Mental Health Crisis Dataset containing 1,800 simulated messages and the NVIDIA Aegis AI Content Safety Dataset subsetted to 794 mental health-related messages. The two datasets were clinician-labelled and we evaluated performance using the clinician labels. Additionally, we carried out comparative performance analyses against two open source, content moderation guardrails: OpenAI Omni Moderation Latest and NVIDIA NeMo Guardrails. The VBHSF demonstrated, well-balanced performance on the Verily Mental Health Crisis Dataset v1.0, achieving high sensitivity (0.990) and specificity (0.992) in detecting any mental health crises. It achieved an F1-score of 0.939, sensitivity ranged from 0.917-0.992, and specificity was >= 0.978 in identifying specific crisis categories. When evaluated against the NVIDIA Aegis AI Content Safety Dataset 2.0, VBHSF performance remained highly sensitive (0.982) and accuracy (0.921) with reduced specificity (0.859). When compared with the NVIDIA NeMo and OpenAI Omni Moderation Latest guardrails, the VBHSF demonstrated superior performance metrics across both datasets, achieving significantly higher sensitivity in all cases (all p < 0.001) and higher specificity relative to NVIDIA NeMo (p < 0.001), but not to OpenAI Omni Moderation Latest (p = 0.094). NVIDIA NeMo and OpenAI Omni Moderation Latest exhibited inconsistent performance across specific crisis types, with sensitivity for some categories falling below 0.10. Overall, the VBHSF demonstrated robust, generalizable performance that prioritizes sensitivity to minimize missed crises, a crucial feature for healthcare applications.

Chemical pretrained models, sometimes referred to as foundation models, are receiving considerable interest for drug discovery applications. The general chemical knowledge extracted from self-supervised training has the potential to improve predictions for critical drug discovery endpoints, including on-target potency and ADMET properties. Multi-task learning has previously been successfully leveraged to improve predictive models. Here, we show that enabling multitasking in finetuning of chemical pretrained graph neural network models such as Kinetic GROVER Multi-Task (KERMT), an enhanced version of the GROVER model, and Knowledge-guided Pre-training of Graph Transformer (KGPT) significantly improves performance over non-pretrained graph neural network models. Surprisingly, we find that the performance improvement from finetuning KERMT in a multitask manner is most significant at larger data sizes. Additionally, we publish two multitask ADMET data splits to enable more accurate benchmarking of multitask deep learning methods for drug property prediction. Finally, we provide an accelerated implementation of the KERMT model on GitHub, unlocking large-scale pretraining, finetuning, and inference in industrial drug discovery workflows.

In-context learners like TabPFN are promising for biomolecule efficacy prediction, where established molecular feature sets and relevant experimental results can serve as powerful contextual examples. However, their performance is highly sensitive to the provided context, making strategies like post-hoc ensembling of models trained on different data subsets a viable approach. An open question is how to select the best models for the ensemble without access to ground truth labels. In this study, we investigate an uncertainty-guided strategy for model selection. We demonstrate on an siRNA knockdown efficacy task that a TabPFN model using straightforward sequence-based features can surpass specialized state-of-the-art predictors. We also show that the model's predicted inter-quantile range (IQR), a measure of its uncertainty, has a negative correlation with true prediction error. We developed the OligoICP method, which selects and averages an ensemble of models with the lowest mean IQR for siRNA efficacy prediction, achieving superior performance compared to naive ensembling or using a single model trained on all available data. This finding highlights model uncertainty as a powerful, label-free heuristic for optimizing biomolecule efficacy predictions.

Reasoning protocols such as Chain of Thought (CoT) and Tree of Thought (ToT) organize internal deliberation but lack an explicit mechanism for external questioning that elicits self-revision. We present FOR-Prompting (From Objection to Revision Prompting), an asymmetric protocol where a Defender proposes an answer, an Objectioner raises question-style objections with no direct fixes, and a Host enforces consistency and closure. On GSM8K we observe about a 22% point gain over single-prompt and accuracy on par with CoT, with more than 10% higher ratings in reasoning and coherence from a uniform GPT 4.1 judge. FOR-Prompting also corrects mistakes without tools or human supervision on tricky queries, and improves performance for small-scale model (approx. 19% accuracy improved on Llama3.2:1b for GSM8K task), highlighting promise for small models and on personal device use. Beyond factual QA, qualitative analyses on open-ended tasks show enhanced exploration and refinement, with dialogue traces that make assumptions and trade-offs explicit. The protocol is model agnostic and operates purely at the prompt level through role-structured turns, so it works with hosted and local models of different sizes without retraining, and it supports large-scale study of objection-guided reasoning.

We introduce Ibex, a pan-immunoglobulin structure prediction model that achieves state-of-the-art accuracy in modeling the variable domains of antibodies, nanobodies, and T-cell receptors. Unlike previous approaches, Ibex explicitly distinguishes between bound and unbound protein conformations by training on labeled apo and holo structural pairs, enabling accurate prediction of both states at inference time. Using a comprehensive private dataset of high-resolution antibody structures, we demonstrate superior out-of-distribution performance compared to existing specialized and general protein structure prediction tools. Ibex combines the accuracy of cutting-edge models with significantly reduced computational requirements, providing a robust foundation for accelerating large molecule design and therapeutic development.

Early multiple sclerosis (MS) disability progression prediction is challenging due to disease heterogeneity. This work predicts 48- and 72-week disability using sparse baseline clinical data and 12 weeks of daily digital Floodlight data from the CONSONANCE clinical trial. We employed state-of-the-art tabular and time-series foundation models (FMs), a custom multimodal attention-based transformer, and machine learning methods. Despite the difficulty of early prediction (AUROC 0.63), integrating digital data via advanced models improved performance over clinical data alone. A transformer model using unimodal embeddings from the Moment FM yielded the best result, but our multimodal transformer consistently outperformed its unimodal counterpart, confirming the advantages of combining clinical with digital data. Our findings demonstrate the promise of FMs and multimodal approaches to extract predictive signals from complex and diverse clinical and digital life sciences data (e.g., imaging, omics), enabling more accurate prognostics for MS and potentially other complex diseases.

Large Language Models (LLMs) have gained significant popularity in recent years. Differentiating between a text written by a human and a text generated by an LLM has become almost impossible. Information hiding techniques such as digital watermarking or steganography can help by embedding information inside text without being noticed. However, existing techniques, such as linguistic-based or format-based methods, change the semantics or do not work on pure, unformatted text. In this paper, we introduce a novel method for information hiding termed TREND, which is able to conceal any byte-encoded sequence within a cover text. The proposed method is implemented as a multi-platform library using the Kotlin programming language, accompanied by a command-line tool and a web interface provided as examples of usage. By substituting conventional whitespace characters with visually similar Unicode whitespace characters, our proposed scheme preserves the semantics of the cover text without increasing the number of characters. Furthermore, we propose a specified structure for secret messages that enables configurable compression, encryption, hashing, and error correction. Our experimental benchmark comparison on a dataset of one million Wikipedia articles compares ten algorithms from literature and practice. It proves the robustness of our proposed method in various applications while remaining imperceptible to humans. We discuss the limitations of limited embedding capacity and further robustness, which guide implications for future work.

Accurate prediction of molecular activities is crucial for efficient drug discovery, yet remains challenging due to limited and noisy datasets. We introduce Similarity-Quantized Relative Learning (SQRL), a learning framework that reformulates molecular activity prediction as relative difference learning between structurally similar pairs of compounds. SQRL uses precomputed molecular similarities to enhance training of graph neural networks and other architectures, and significantly improves accuracy and generalization in low-data regimes common in drug discovery. We demonstrate its broad applicability and real-world potential through benchmarking on public datasets as well as proprietary industry data. Our findings demonstrate that leveraging similarity-aware relative differences provides an effective paradigm for molecular activity prediction.

Genetic screens mediated via CRISPR-Cas9 combined with high-content readouts have emerged as powerful tools for biological discovery. However, computational analyses of these screens come with additional challenges beyond those found with standard scRNA-seq analyses. For example, perturbation-induced variations of interest may be subtle and masked by other dominant source of variation shared with controls, and variable guide efficiency results in some cells not undergoing genetic perturbation despite expressing a guide RNA. While a number of methods have been developed to address the former problem by explicitly disentangling perturbation-induced variations from those shared with controls, less attention has been paid to the latter problem of noisy perturbation labels. To address this issue, here we propose ContrastiveVI+, a generative modeling framework that both disentangles perturbation-induced from non-perturbation-related variations while also inferring whether cells truly underwent genomic edits. Applied to three large-scale Perturb-seq datasets, we find that ContrastiveVI+ better recovers known perturbation-induced variations compared to previous methods while successfully identifying cells that escaped the functional consequences of guide RNA expression. An open-source implementation of our model is available at https://github.